P&G (PG) Health Care CEO Gama Paul Receives 279.192 RSUs

What Happened Gama Paul, Health Care CEO at Procter & Gamble (PG), received a series of restricted stock unit (RSU) awards/adjustments totaling 279.192 RSUs (derivative securities) in filings covering transactions dated May 15, 2026; July 14, 2026; and Aug 6, 2026. The awards were reported as acquired at $0.00 (i.e., granted rather than purchased). These are awards/adjustments rather than open-market purchases or sales and do not by themselves indicate a buy/sell market signal.

Key Details

• Transaction dates and amounts:
  • 2026-05-15: 7.087 RSUs (grant/award)
  • 2026-07-14: 0.105 RSUs (adjustment/grant)
  • 2026-08-06: 272 RSUs (grant/award)
  • Total: 279.192 RSUs; all reported at $0.00 per unit (award/derivative).
• Filing: Form 4 filed Aug 10, 2026, reporting transactions through Aug 6, 2026.
• Shares owned after transaction: Not disclosed in the provided filing data.
• Footnotes of note:
  • F1/F3: Some units include dividend equivalents and/or are RSUs granted under the issuer’s retirement program (contingent rights to receive common stock).
  • F4: Units are generally deliverable in shares on retirement unless delivery is deferred or contributed to a deferred compensation account.
  • F2/F7: One entry reflects an adjustment through July 14, 2026; certain retirement awards are computed per the plan year benefit formula.
  • F5/F6: Other plan-specific details reference conversion/exercise price rules and trustees for retirement-plan-held shares.

Context

• These are derivative awards (RSUs) — a promise to deliver shares (or sometimes cash) under company plans, often tied to retirement or service, not an open-market purchase or sale.
• Awards that are part of retirement or compensation plans are routine for executives and do not necessarily reflect near-term trading intent.